Curavit
PrivateLast Round
Series A
Nov 14, 2022
Total Funding Raised
$8M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Curavit is a life sciences company that provides a virtual contract research organization (VCRO) for designing and executing decentralized clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curavit Comparables
Compare Curavit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lightship | 87% | |
| Curebase | 85% | |
| ObvioHealth | 84% |
Curavit Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Curavit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Osage Venture Partners | Series A |
| Royal Street Ventures | Series A |
| Narrow Gauge Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
Grew 220% QoQ, from 20 to 64 employees.
- Aug 27, 2026
Grew 113% QoQ, from 23 to 49 employees.
Recent news
Latest coverage and updates
- invests_into_assetsAug 23, 2026
Curavit acquires Lindus Health’s clinical research organization (CRO) assets, expanding operations into Europe and enabling life science sponsors to run multi-region studies through a single partner.
- expands_offices_toAug 18, 2026
Curavit expands operations into Europe on Aug 18th '26 through the acquisition of Lindus Health’s CRO assets, adding unified end-to-end services for decentralized, hybrid, and traditional clinical trials across North America and Europe.
Curavit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curavit's valuation, stock price, and market status.
Is Curavit a public or private company?
Curavit is a private company.
What is the current stock price of Curavit?
Curavit is a private company, so its shares have no public market price. Caplight tracks Curavit's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Curavit worth (valuation)?
Valuation information for Curavit is not publicly available.
Can I buy Curavit stock?
Curavit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Curavit's last funding round?
Curavit's most recent funding round was Series A on November 14, 2022.
Who are the main investors in Curavit?
Key investors in Curavit include Osage Venture Partners.
Will Curavit IPO soon?
No public IPO plans have been announced for Curavit.
How can I track Curavit secondary market activity?
Caplight tracks bids, offers, and trades in Curavit's shares on secondary markets.